| Description | NVP-QAV-572 is a inhibitor of PI3K(IC50 of 10 nM). |
| In vitro | NVP-QAV-572 is useful in the treatment of conditions which are mediated by the activation of the Pi3 kinase enzymes, used in inflammatory or allergic conditions[1]. |
| Target activity | PI3K:10 nM |
| molecular weight | 471.5 |
| Molecular formula | C17H19F2N7O3S2 |
| CAS | 957209-68-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 125 mg/mL (265.11 mM), Sonication is recommended. |
| References | 1. Emma Budd, et al. 5-phenyl-thiazol-2-yl-urea derivatives and use as PI3 kinase inhibitors. US 7998990 B2. |